Advertisement

CeriBell, Inc. CBLL

Set alert

Price alert · CBLL

All alert types
26.58 USD -1.24 -4.46%

At close · Oct 30

26.58 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
26.55 × 1
Ask
26.60 × 2
26.01 Day range 27.61
10.92 52-week range 27.82
YTD
+21.20%
1 year
+134.81%
Open
27.48
Prev close
27.82
Mkt cap
1.02B
Vol
582.65K
Avg vol
428.69K
EPS
-1.76
P/E
0.00
Div yield
0.00%
More statistics
Low
26.01
High
27.61
Forward P/E
-16.48
Beta
0.93
Short ratio
5.05
Inst. own
90.77%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
24.88
200-d avg
20.76
1y target
28.57

3M chart

Chart tools
Interval

Events in this range
  • Aug 10, 2026Earnings: -0.51; estimate -0.47119; surprise -8.24%
  • Aug 11, 2026Rating: BTIG · Buy → Buy
  • Aug 11, 2026Rating: Canaccord Genuity · Buy → Buy
  • Aug 18, 2026Rating: BTIG · Buy → Buy
  • Sep 11, 2026Rating: BTIG · Buy → Buy
  • Oct 2, 2026Rating: TD Cowen · Buy → Buy
Signals (14)
NameDateAgo
MACD: Buy SignalOct 13, 20262 weeks ago
SMA: BullishOct 12, 20262 weeks ago
SMA: BearishOct 7, 20263 weeks ago
SMA: BullishOct 5, 20263 weeks ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 28, 20261 month ago
SMA: BearishSep 23, 20261 month ago
RSI: OverboughtSep 4, 20261 month ago
RSI: OverboughtSep 1, 20262 months ago
MACD: Sell SignalAug 28, 20262 months ago
RSI: OverboughtAug 11, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 4, 20262 months ago

Key statistics

Market cap
1.02B
Enterprise value
960.33M
Trailing P/E
0.00
Forward P/E
-16.48
PEG ratio
0.00
Price / sales
10.00
Price / book
7.92
EPS (TTM)
-1.76
Beta
0.93
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-64.73%
Revenue (TTM)
101.96M
Revenue growth
32.50%
Free cash flow
-33.05M
Total cash
129.26M
Total debt
21.91M
Return on equity
-43.93%
Shares outstanding
38.38M
Short % of float
8.61%
50-day average
24.88
200-day average
20.76

Analyst view

Consensus: none

Price target (mean) 28.57 +7.5% upside
Target (low)
24.00
Target (mean)
28.57
Target (high)
33.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy7
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Nov 3, 2026

Expected Nov 3, 2026. Consensus EPS estimate -0.51532.

Earnings history

Financials — quick view

All financials
CBLL Revenue — quarterly 28.10M
2023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CBLL Net income — quarterly -19.27M
2023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CBLL EPS — quarterly -0.51
2023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CBLL recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 3, 2026Sep 30, 2026-0.50———
Aug 10, 2026Jun 30, 2026-0.47119-0.51-0.04-8.24%
May 11, 2026Mar 31, 2026-0.39-0.52-0.13-33.33%
Feb 24, 2026Dec 31, 2025-0.43-0.36+0.07+16.28%
Nov 4, 2025Sep 30, 2025-0.43-0.37+0.06+13.95%
Aug 5, 2025Jun 30, 2025-0.40-0.38+0.02+5.00%

Upgrades / downgrades

CBLL analyst upgrades and downgrades
DateFirmActionFromTo
Oct 2, 2026TD CowenmainBuyBuy
Sep 11, 2026BTIGreitBuyBuy
Aug 18, 2026BTIGmainBuyBuy
Aug 11, 2026Canaccord GenuitymainBuyBuy
Aug 11, 2026BTIGreitBuyBuy
May 12, 2026Canaccord GenuitymainBuyBuy

About CeriBell, Inc.

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
ceribell.com

News

Your note

Sign in to keep a note on CBLL — it syncs with the Stock Master app.

Insider holders

CBLL insider holders
InsiderRelationLatest transactionDateShares held
BLUMBERG SCOTTChief Financial OfficerSaleSep 14, 2026146,600
CHAO XINGJUANChief Executive OfficerSaleSep 14, 20261,115,430
FOEHR DAVIDOfficerSaleSep 7, 202634,144
MANNI JOSEPH SOfficerSaleAug 20, 202655,956
PARVIZI JOSEFDirectorStock Award(Grant)Jun 1, 20262,007,490
ROGERS ERICA J.DirectorStock Award(Grant)Jun 1, 202633,054

Institution ownership

CBLL institution ownership
Holder% heldSharesValueReported
FMR, LLC14.83%5,691,393151.28MJun 29, 2026
TPG GP A, LLC9.80%3,761,15499.97MJun 29, 2026
Red Tree Management, LLC 5.75%2,205,66158.63MSep 29, 2026
Blackrock Inc.5.04%1,936,09351.46MJun 29, 2026
Vanguard Capital Management LLC2.95%1,130,34630.04MJun 29, 2026
KCM Capital Inc2.93%1,125,00029.90MJun 29, 2026

Fund ownership

CBLL fund ownership
Holder% heldSharesValueReported
Fidelity Securities Fund-Fidelity Small Cap Growth Fund4.27%1,637,48543.52MJul 30, 2026
Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund2.61%1,002,88926.66MJul 30, 2026
Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund2.45%939,25124.97MJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.22%850,44322.60MJun 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund2.16%830,54522.08MJul 30, 2026
Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND1.95%750,21919.94MJul 30, 2026
Advertisement